Last Funding Type: Post-IPO Equity
Total Funding: 775000000
Last Funding Date: 2021-06-30
Funding Status: IPO
Employee Number: 251-500
Estimated Revenue: $10M to $50M
Investors Number: 9
Founded Date: 1/1/2014
Headquarters: Cambridge, Massachusetts, United States
Industry: Gene therapy